Rezultati - Peter S. Hammerman

Refine Results
  1. 1
    Genomic Landscape of Human Papillomavirus–Associated Cancers

    Genomic Landscape of Human Papillomavirus–Associated Cancers od Maria Rusan, Yvonne Y. Li, Peter S. Hammerman

    Izdano 2015
    Polni tekst Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  2. 2
    The Pim kinases control rapamycin-resistant T cell survival and activation

    The Pim kinases control rapamycin-resistant T cell survival and activation od Casey Fox, Peter S. Hammerman, Craig B. Thompson

    Izdano 2005
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  3. 3
    Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non–Small Cell Lung Cancer

    Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non–Small Cell Lung Cancer od Peter S. Hammerman, Pasi A. Jänne, Bruce E. Johnson

    Izdano 2009
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  4. 4
    Therapeutic Insights from Genomic Studies of Head and Neck Squamous Cell Carcinomas

    Therapeutic Insights from Genomic Studies of Head and Neck Squamous Cell Carcinomas od Peter S. Hammerman, D. Neil Hayes, Jennifer R. Grandis

    Izdano 2015
    Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  5. 5
    Pim and Akt oncogenes are independent regulators of hematopoietic cell growth and survival

    Pim and Akt oncogenes are independent regulators of hematopoietic cell growth and survival od Peter S. Hammerman, Casey Fox, Morris J. Birnbaum, Craig B. Thompson

    Izdano 2005
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  6. 6
    Non-small-cell lung cancers: a heterogeneous set of diseases

    Non-small-cell lung cancers: a heterogeneous set of diseases od Chen Zhao, Christine M. Fillmore, Peter S. Hammerman, Carla F. Kim, Kwok‐Kin Wong

    Izdano 2014
    Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  7. 7
    Squamous Cell Lung Cancer: From Tumor Genomics to Cancer Therapeutics

    Squamous Cell Lung Cancer: From Tumor Genomics to Cancer Therapeutics od David R. Gandara, Peter S. Hammerman, Martin L. Sos, Primo N. Lara, Fred R. Hirsch

    Izdano 2015
    Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  8. 8
    The serine/threonine kinase Pim-2 is a transcriptionally regulated apoptotic inhibitor

    The serine/threonine kinase Pim-2 is a transcriptionally regulated apoptotic inhibitor od Casey Fox, Peter S. Hammerman, Ryan M. Cinalli, Stephen R. Master, Lewis A. Chodosh, Craig B. Thompson

    Izdano 2003
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  9. 9
    Akt-Directed Glucose Metabolism Can Prevent Bax Conformation Change and Promote Growth Factor-Independent Survival

    Akt-Directed Glucose Metabolism Can Prevent Bax Conformation Change and Promote Growth Factor-Independent Survival od Jeffrey C. Rathmell, Casey Fox, David R. Plas, Peter S. Hammerman, Ryan M. Cinalli, Craig B. Thompson

    Izdano 2003
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  10. 10
    Lymphocyte Transformation by Pim-2 Is Dependent on Nuclear Factor-κB Activation

    Lymphocyte Transformation by Pim-2 Is Dependent on Nuclear Factor-κB Activation od Peter S. Hammerman, Casey Fox, Ryan M. Cinalli, Anne Xu, John D. Wagner, Tullia Lindsten, Craig B. Thompson

    Izdano 2004
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  11. 11
    Genomic Analysis of Metastatic Cutaneous Squamous Cell Carcinoma

    Genomic Analysis of Metastatic Cutaneous Squamous Cell Carcinoma od Yvonne Y. Li, Glenn J. Hanna, Alvaro C. Laga, Robert I. Haddad, Jochen H. Lorch, Peter S. Hammerman

    Izdano 2015
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  12. 12
    Characterization of DDR2 Inhibitors for the Treatment of <i>DDR2</i> Mutated Nonsmall Cell Lung Cancer

    Characterization of DDR2 Inhibitors for the Treatment of <i>DDR2</i> Mutated Nonsmall Cell Lung Cancer od Hideki Terai, Li Tan, Ellen M. Beauchamp, John M. Hatcher, Qingsong Liu, Matthew Meyerson, Nathanael S. Gray, Peter S. Hammerman

    Izdano 2015
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  13. 13
    Multiple signaling pathways promote B lymphocyte stimulator–dependent B-cell growth and survival

    Multiple signaling pathways promote B lymphocyte stimulator–dependent B-cell growth and survival od Robert T. Woodland, Casey Fox, Madelyn R. Schmidt, Peter S. Hammerman, Joseph T. Opferman, Stanley J. Korsmeyer, David M. Hilbert, Craig B. Thompson

    Izdano 2007
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  14. 14
    Intravenous methotrexate as central nervous system (CNS) prophylaxis is associated with a low risk of CNS recurrence in high‐risk patients with diffuse large B‐cell lymphoma

    Intravenous methotrexate as central nervous system (CNS) prophylaxis is associated with a low risk of CNS recurrence in high‐risk patients with diffuse large B‐cell lymphoma od Jeremy S. Abramson, Matthew D. Hellmann, Jeffrey A. Barnes, Peter S. Hammerman, Christiana E. Toomey, Tak Takvorian, Alona Muzikansky, Ephraim P. Hochberg

    Izdano 2010
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  15. 15
    Ligand-associated ERBB2/3 activation confers acquired resistance to FGFR inhibition in FGFR3-dependent cancer cells

    Ligand-associated ERBB2/3 activation confers acquired resistance to FGFR inhibition in FGFR3-dependent cancer cells od Jun Wang, Oliver R. Mikse, Rachel G. Liao, Yi Li, Li Tan, Pasi A. Jänne, Nathanael S. Gray, K-k Wong, Peter S. Hammerman

    Izdano 2014
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  16. 16
    Cytokine stimulation of aerobic glycolysis in hematopoietic cells exceeds proliferative demand

    Cytokine stimulation of aerobic glycolysis in hematopoietic cells exceeds proliferative demand od Daniel E. Bauer, Marian H. Harris, David R. Plas, Julian J. Lum, Peter S. Hammerman, Jeffrey C. Rathmell, James L. Riley, Craig B. Thompson

    Izdano 2004
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  17. 17
    Treatment-Related Toxicities in a Phase II Trial of Dasatinib in Patients with Squamous Cell Carcinoma of the Lung

    Treatment-Related Toxicities in a Phase II Trial of Dasatinib in Patients with Squamous Cell Carcinoma of the Lung od Andrew M. Brunner, Daniel B. Costa, Rebecca S. Heist, Elizabeth Garcia, Neal I. Lindeman, Lynette M. Sholl, Geoffrey R. Oxnard, Bruce E. Johnson, Peter S. Hammerman

    Izdano 2013
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  18. 18
    Acquired Resistance to Dasatinib in Lung Cancer Cell Lines Conferred by<i>DDR2</i>Gatekeeper Mutation and<i>NF1</i>Loss

    Acquired Resistance to Dasatinib in Lung Cancer Cell Lines Conferred by<i>DDR2</i>Gatekeeper Mutation and<i>NF1</i>Loss od Ellen M. Beauchamp, Brittany A. Woods, Austin Dulak, Li Tan, Chunxiao Xu, Nathanael S. Gray, Adam J. Bass, Kwok‐Kin Wong, Matthew Meyerson, Peter S. Hammerman

    Izdano 2013
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  19. 19
    Inhibitor-Sensitive FGFR1 Amplification in Human Non-Small Cell Lung Cancer

    Inhibitor-Sensitive FGFR1 Amplification in Human Non-Small Cell Lung Cancer od Amit Dutt, Alex H. Ramos, Peter S. Hammerman, Craig H. Mermel, Jeonghee Cho, Tanaz Sharifnia, Ajit Chande, Kumiko Tanaka, Nicolas Stransky, Heidi Greulich, Nathanael S. Gray, Matthew Meyerson

    Izdano 2011
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  20. 20
    Resistance to allosteric SHP2 inhibition in FGFR-driven cancers through rapid feedback activation of FGFR

    Resistance to allosteric SHP2 inhibition in FGFR-driven cancers through rapid feedback activation of FGFR od Hengyu Lu, Chen Liu, Hung Huynh, Thi Bich Uyen Le, Matthew J. LaMarche, Morvarid Mohseni, Jeffrey A. Engelman, Peter S. Hammerman, Giordano Caponigro, Huai‐Xiang Hao

    Izdano 2020
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:

Iskalna orodja: